A randomized, prospective controlled pilot study between UKA and TKA - UKA/TKA Study

Zimmer K.K.0 sites20 target enrollmentMarch 12, 2013

Overview

No summary available.

Registry

who.int

Start Date

March 12, 2013

End Date

December 31, 2017

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Zimmer K.K.

•1\).Patient is currently participating in any other surgical intervention studies or pain management studies 2\).Patient with previous history of infection in the affected joint and/or local/systemic infection that may affect the prosthetic joint 3\).Patient with insufficient bone stock on femoral or tibial surfaces 4\).Patient with skeletal immaturity 5\).Patient with neuropathic arthropathy 6\).Patient with chondrocalcinosis 7\).Patient with osteoporosis or any loss of musculature or neuromuscular disease that compromises the affected limb 8\).Patient with damage to the articular cartilage of the opposite compartment 9\).Patient with inflammatory synovitis 10\).Patient with eburnation in the patellofemoral joint 11\).Patient with a stable, painless arthrodesis in a satisfactory functional position 12\).Patient with severe instability secondary to the absence of collateral ligament integrity 13\).Patient with an ulcer of the skin or a history of recurrent breakdown of the skin 14\).Patient with history of deep vein thrombosis (DVT) or pulmonary embolism (PE) 15\).Patient has a known or suspected sensitivity or allergy to one or more of the implant materials 16\).Patient is pregnant or considered a member of a protected population (e.g., prisoner, mentally incompetent, etc.)